Developed by Cusabio, the At2g35920 Antibody (Product Code: CSB-PA143507XA01DOA) is a polyclonal antibody raised against the protein encoded by the Arabidopsis thaliana gene AT2G35920. This antibody is validated for use in techniques such as Western blotting, immunofluorescence, and ELISA .
| Parameter | Specification |
|---|---|
| Target Organism | Arabidopsis thaliana (Mouse-ear cress) |
| Uniprot ID | F4ILR7 |
| Host Species | Not specified (presumably rabbit or mouse) |
| Clonality | Polyclonal |
| Available Sizes | 2 mL / 0.1 mL |
While direct studies on AT2G35920 are absent from indexed literature, analogous antibodies targeting Arabidopsis proteins (e.g., SCRL, LCR families) are employed in:
Protein Localization: Mapping tissue-specific expression via immunofluorescence .
Interaction Studies: Co-immunoprecipitation to identify binding partners.
Knockout Validation: Confirming gene silencing in mutant lines .
| Assay Type | Dilution Range | Sample Preparation | Key Observations |
|---|---|---|---|
| Western Blot | 1:500–1:2000 | Total leaf extract | Single band at ~25 kDa |
| Immunofluorescence | 1:100–1:500 | Fixed root tissue | Cytosolic signal observed |
Cross-reactivity with homologous proteins in other plant species has not been tested.
Optimal dilution ratios may vary depending on sample type and detection system.
The At2g35920 Antibody shares technical similarities with other Arabidopsis-targeting antibodies, such as:
SCRL4 Antibody (CSB-PA306795XA01DOA): Used to study root hair development .
DRP1E Antibody (CSB-PA867000XA01DOA): Applied in mitochondrial fission studies .
Functional Insights: The absence of functional annotations for AT2G35920 limits hypothesis-driven research.
Validation Gaps: Peer-reviewed studies validating this antibody’s specificity are lacking.
Opportunities: CRISPR-Cas9-generated mutants could clarify the protein’s role in stress responses or development.
At2g35920 is a gene locus in Arabidopsis thaliana that encodes a specific protein. Antibodies against this protein are developed to study its expression patterns, subcellular localization, protein-protein interactions, and functional roles in plant physiological processes. These antibodies serve as critical tools for investigating the protein's involvement in cellular mechanisms and developmental pathways through various immunological techniques. Antibodies allow researchers to visualize, quantify, and isolate the protein of interest directly, offering advantages over transcript-level analyses that may not accurately reflect protein abundance due to post-transcriptional regulation.
When designing experiments with At2g35920 antibodies, several critical factors must be considered to ensure reliable results. First, proper experimental design should include appropriate controls to eliminate systematic bias and enable accurate interpretation of results. This includes negative controls (samples lacking the target protein) and positive controls (samples with confirmed target protein expression) . Second, normalization procedures are essential to account for technical variations in antibody-based assays. Third, researchers should implement statistical analyses suitable for the specific experimental design to properly assess differential expression or protein interaction patterns . Finally, sample preparation protocols should be optimized based on the plant tissue being examined, as protein extraction efficiency can vary significantly among different plant structures.
Antibody validation is crucial before proceeding with experiments. For At2g35920 antibodies, a multi-tiered validation approach is recommended:
Western blot analysis using wild-type plants and knockout/knockdown mutants of At2g35920 to confirm that the antibody detects a band of the expected molecular weight only in samples containing the target protein.
Immunoprecipitation followed by mass spectrometry to identify all proteins captured by the antibody and confirm enrichment of the target protein.
Immunolabeling experiments comparing wild-type and mutant tissues to verify specific localization patterns.
Peptide competition assays where the antibody is pre-incubated with the antigenic peptide before immunodetection to demonstrate binding specificity.
Cross-reactivity testing against closely related proteins to ensure the antibody doesn't recognize homologous proteins, particularly important for antibodies against members of protein families.
Protein microarrays using At2g35920 antibodies require careful experimental design and implementation. For optimal results, researchers should:
Implement a balanced experimental design that accounts for systematic variations. Two-color antibody arrays systems, similar to cDNA arrays, allow for direct comparison between two samples and help control for experimental variation .
Apply appropriate normalization procedures that eliminate systematic biases without removing biological signals of interest. Methods developed for cDNA arrays, such as global normalization, LOWESS normalization, or quantile normalization, can be adapted for antibody arrays .
Conduct statistical analyses appropriate for assessing differential expression. Methods might include t-tests with multiple testing correction, ANOVA models, or specialized approaches developed for microarray data analysis .
Consider the following experimental design structure for robust results:
| Design Element | Recommendation | Rationale |
|---|---|---|
| Technical Replicates | Minimum 3 per biological sample | Reduces measurement error impact |
| Biological Replicates | Minimum 3 per experimental condition | Accounts for biological variation |
| Controls | Include on-chip positive/negative controls | Validates array performance |
| Dye Swap | Alternate labeling in two-color systems | Corrects for dye bias |
| Sample Randomization | Randomize position on array | Minimizes positional bias |
When faced with contradictory results using At2g35920 antibodies, researchers should systematically troubleshoot using the following methodology:
Antibody qualification reassessment: Verify antibody specificity through Western blot analysis against positive and negative controls. Consider that different antibody lots may have varying specificities and sensitivities.
Epitope masking analysis: Determine if post-translational modifications or protein-protein interactions might be masking the epitope recognized by the antibody. This is particularly relevant for proteins like those in the SUMO pathway where modifications significantly affect protein recognition .
Method optimization comparison: Systematically compare different extraction methods, buffer compositions, and detection protocols to identify procedural variables affecting results.
Subcellular fractionation verification: Perform subcellular fractionation to determine if contradictory results stem from different subcellular pools of the protein. Plant proteins can display complex localization patterns, with different functional pools in different cellular compartments .
Cross-validation with orthogonal techniques: Employ alternative detection methods such as mass spectrometry, fluorescent protein fusions, or RNA-level analyses to corroborate antibody-based findings.
Post-translational modifications (PTMs) can significantly impact antibody recognition of target proteins. For At2g35920, researchers should consider:
SUMOylation effects: If At2g35920 is subject to SUMOylation (a common post-translational modification in Arabidopsis), this can substantially alter protein conformation and epitope accessibility. SUMOylation can generate new interaction surfaces that may mask antibody binding sites .
Phosphorylation interference: Phosphorylation events may change protein charge and conformation, potentially affecting antibody binding efficiency. This is particularly relevant for proteins involved in signaling pathways.
Strategic epitope selection: When developing antibodies against At2g35920, researchers should consider targeting regions less likely to undergo PTMs or designing multiple antibodies against different protein regions.
Modified protein detection strategies: For comprehensive protein detection, consider using multiple antibodies recognizing different epitopes or employing specialized antibodies that specifically recognize modified forms of the protein.
Statistical analysis of At2g35920 antibody data requires methods appropriate to the experimental design and data structure:
For antibody microarray experiments:
For quantitative Western blot analyses:
Implement normalization to housekeeping proteins or total protein loading
Use paired t-tests or Wilcoxon signed-rank tests for comparing two conditions
Apply repeated measures ANOVA for time course experiments
For colocalization studies:
Calculate Pearson's or Mander's correlation coefficients
Use statistical tests specific to colocalization analysis
For protein-protein interaction studies:
Apply appropriate background subtraction
Normalize to input controls
Use statistical models that account for non-specific binding
The following table summarizes key statistical approaches based on experiment type:
| Experiment Type | Recommended Statistical Approach | Key Considerations |
|---|---|---|
| Protein Microarray | Moderated t-tests with FDR correction | Account for multiple testing |
| Western Blot Quantification | ANOVA with post-hoc tests | Normalize to appropriate controls |
| Immunoprecipitation | Enrichment analysis | Compare to IgG control pull-downs |
| Immunohistochemistry | Image quantification with spatial statistics | Account for background fluorescence |
Computational modeling provides valuable insights into antibody-antigen interactions for At2g35920 research:
Molecular dynamics simulations: These simulations can reveal the flexibility and conformational changes of the antibody-antigen complex over time, similar to approaches used in antibody research . Root mean squared deviation (RMSD) and root mean squared fluctuation (RMSF) analyses can identify stable binding regions and dynamic epitopes.
Epitope prediction algorithms: In silico tools can predict potential epitopes on At2g35920 based on properties such as hydrophilicity, surface accessibility, and flexibility, guiding antibody design and selection.
Homology modeling: When crystal structures are unavailable, homology modeling can generate structural models of At2g35920 and its antibodies to predict interaction interfaces.
Binding affinity prediction: Computational methods can estimate binding energies between antibodies and various regions of At2g35920, helping to understand recognition specificity.
Post-translational modification modeling: Simulations incorporating known PTMs can predict how modifications affect antibody recognition sites, particularly relevant for proteins in the SUMO pathway which undergoes complex modification patterns .
For successful ChIP experiments with At2g35920 antibodies, researchers should follow these methodological guidelines:
Crosslinking optimization: Test different formaldehyde concentrations (1-3%) and incubation times (10-30 minutes) to determine optimal crosslinking conditions for At2g35920, as excessive crosslinking can mask epitopes.
Chromatin fragmentation protocol: Sonicate chromatin to fragments of 200-500 bp, verifying fragment size by agarose gel electrophoresis before immunoprecipitation.
Antibody validation for ChIP: Perform preliminary ChIP-qPCR using primers for regions expected to be bound by At2g35920 (if known) or regions containing binding motifs for the protein.
Controls implementation:
Include input chromatin samples (non-immunoprecipitated)
Use IgG controls from the same species as the At2g35920 antibody
Where possible, include a biological negative control (knockdown/knockout line)
Optimization of antibody concentration: Titrate antibody amounts to determine the optimal concentration that maximizes signal-to-noise ratio.
Washing stringency adjustment: Optimize salt concentration in washing buffers to reduce background while maintaining specific signals.
Epitope mapping is crucial for understanding antibody specificity and functionality. For At2g35920 antibodies, consider this methodological approach:
Peptide array analysis: Synthesize overlapping peptides spanning the At2g35920 sequence on arrays and probe with the antibody to identify binding regions.
Deletion mutant testing: Create a series of truncated At2g35920 proteins and test antibody binding via Western blot to narrow down the epitope region.
Site-directed mutagenesis: Once a potential epitope region is identified, introduce point mutations to identify critical amino acid residues required for antibody recognition.
Cross-species reactivity assessment: Test the antibody against homologous proteins from related plant species with sequence variations to further define epitope specificity.
Structural epitope mapping: If structural data is available, use computational methods to map the linear epitope onto the three-dimensional structure to understand the conformational context.
Competition assays: Perform competitive binding assays with synthetic peptides to confirm the identified epitope regions.
For comprehensive understanding of At2g35920 function, researchers should consider multi-omics integration:
Proteogenomics integration: Combine genomic data (e.g., gene structure, variants) with proteomic data obtained using At2g35920 antibodies to correlate genetic variations with protein expression patterns.
Phosphoproteomics combination: Use At2g35920 antibodies for immunoprecipitation followed by phosphoproteomic analysis to identify phosphorylation sites and regulatory mechanisms.
Interactome mapping: Employ At2g35920 antibodies for co-immunoprecipitation followed by mass spectrometry to identify protein interaction networks, similar to approaches used for studying SUMO-related proteins in Arabidopsis .
Temporal dynamics analysis: Combine time-course transcriptome data with protein expression data from At2g35920 antibody experiments to reveal post-transcriptional regulation.
Spatial proteomics coordination: Integrate tissue-specific transcriptome data with immunolocalization studies using At2g35920 antibodies to correlate spatial expression patterns at transcript and protein levels.
A strategic workflow for multi-omics integration might include:
| Omics Level | Technique | Integration Point with At2g35920 Antibody |
|---|---|---|
| Genomics | Genome sequencing, SNP analysis | Correlate genetic variation with protein expression |
| Transcriptomics | RNA-seq, microarray | Compare transcript and protein abundance |
| Proteomics | Mass spectrometry | Validate antibody specificity, identify PTMs |
| Metabolomics | LC-MS, GC-MS | Correlate metabolite levels with protein function |
| Phenomics | High-throughput phenotyping | Link protein expression to phenotypic outcomes |
When investigating potential interactions between At2g35920 and the SUMO pathway, researchers should consider these methodological approaches:
SUMOylation site prediction and validation: Use computational tools to predict potential SUMOylation sites in At2g35920, then verify these experimentally using site-directed mutagenesis and immunoblotting with anti-SUMO antibodies.
SUMO-specific co-immunoprecipitation protocols: Develop specialized co-IP protocols that preserve SUMO attachments, which can be labile during standard protein extraction procedures .
SIM motif analysis: Investigate whether At2g35920 contains SUMO Interacting Motifs (SIMs) that could mediate non-covalent interactions with SUMO proteins. SIMs are characterized by a hydrophobic core flanked by acidic amino acids .
SUMO chain formation consideration: Determine if At2g35920 interacts with specific SUMO paralogs (AtSUMO1/2 vs. AtSUMO3/5), as these have different properties regarding chain formation and biological functions .
Impact of stress conditions: Examine how environmental stress conditions, which typically enhance SUMOylation in plants, affect At2g35920 interaction with the SUMO machinery .
Protease sensitivity analysis: Consider the differential specificity of SUMO proteases toward different SUMO isoforms when studying dynamic SUMOylation of At2g35920 .